Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T helper type 1 cytokine secretion" refers to the process by which **T helper type 1 cells** (Th1 cells), a subset of CD4+ T lymphocytes, produce and secrete specific pro-inflammatory cytokines. The primary cytokines secreted by Th1 cells include **interferon gamma (IFNγ)**, **tumor necrosis factor alpha/beta (TNFα/β)**, and interleukin 2 (**IL2**)[5][7][8]. These secreted factors are crucial for activating macrophages, enhancing their microbicidal activity against intracellular pathogens such as Mycobacterium tuberculosis[3][5]. The differentiation of naive CD4+ T cells into the Th1 lineage is driven mainly by exposure to IL12 and IFNγ in the local environment during antigen presentation; this process involves key transcription factors such as STAT4 and T-bet[1][6]. While essential for protective immunity against many infections and tumors, dysregulated or excessive Th1-type responses are implicated in various autoimmune diseases—including Crohn's disease, organ-specific autoimmunity—and chronic inflammatory conditions[7]. Note on correctness ("is_incorrect"): "T helper cell type 1 cytokine secretion" is not itself a molecular target but rather describes a cellular function or process. It does not refer to a single protein, receptor, enzyme, or druggable entity but instead encompasses the collective action of multiple molecules produced by differentiated immune cells. For structured databases focused on molecular targets suitable for pharmacological intervention—such as receptors or enzymes—this entry would be considered incorrect or too broad[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T helper type 1 cytokine secretion (Th1 cytokine secretion).